IGC Pharma Files 8-K
Ticker: IGC · Form: 8-K · Filed: Jun 17, 2025 · CIK: 1326205
| Field | Detail |
|---|---|
| Company | Igc Pharma, Inc. (IGC) |
| Form Type | 8-K |
| Filed Date | Jun 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, SEC filing, financial-reporting
TL;DR
IGC Pharma filed an 8-K on 6/17/25. Standard disclosure.
AI Summary
IGC Pharma, Inc. filed an 8-K on June 17, 2025, reporting other events and financial statements. The company, formerly known as India Globalization Capital, Inc., is incorporated in Maryland and has its principal executive offices in Potomac, Maryland.
Why It Matters
This filing indicates a routine update or disclosure from IGC Pharma, Inc. to the SEC, which may contain important information for investors regarding the company's operations or financial status.
Risk Assessment
Risk Level: low — This is a standard 8-K filing for reporting events and financial statements, not indicating any immediate or significant operational changes or risks.
Key Numbers
- 001-32830 — Commission File Number (SEC filing identifier for IGC Pharma, Inc.)
- 20-2760393 — I.R.S. Employer Identification No. (Tax identification number for IGC Pharma, Inc.)
Key Players & Entities
- IGC Pharma, Inc. (company) — Registrant
- India Globalization Capital, Inc. (company) — Former company name
- June 17, 2025 (date) — Date of earliest event reported
- Maryland (jurisdiction) — State of incorporation
- Potomac, Maryland (location) — Address of principal executive offices
FAQ
What specific 'Other Events' are being reported in this 8-K filing?
The filing indicates 'Other Events' as an item information, but the specific details of these events are not provided in the excerpt.
What is the significance of the 'Financial Statements and Exhibits' being filed?
This suggests that the company is providing updated financial information or exhibits as part of this report, which could include financial statements.
When was IGC Pharma, Inc. formerly known as India Globalization Capital, Inc.?
The filing states the former company name was India Globalization Capital, Inc. and the date of the name change was May 5, 2005.
What is the fiscal year end for IGC Pharma, Inc.?
The fiscal year end for IGC Pharma, Inc. is March 31.
What is the SIC code for IGC Pharma, Inc.?
The Standard Industrial Classification (SIC) code for IGC Pharma, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 17, 2025 regarding IGC Pharma, Inc. (IGC).